Chhaganlal D Ladani, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 27 Heckel Rd Ste 101, Mc Kees Rocks, PA 15136 Phone: 412-777-4366 Fax: 412-777-4369 |
Dr. Amit Ladani, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 27 Heckel Rd Ste 101, Mc Kees Rocks, PA 15136 Phone: 412-777-4366 Fax: 412-777-4369 |
Dr. Thomas Patrick Power, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 133 Church Hill Rd Ste 2a, Mc Kees Rocks, PA 15136 Phone: 412-359-5822 Fax: 412-359-6620 |
News Archive
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
Vaccines and antibiotics may someday join caloric restriction or bariatric surgery as a way to regulate weight gain, according to a new study focused on the interactions between diet, the bacteria that live in the bowel, and the immune system.
"If Stephen Harper is serious about maternal health and child health [as suggested by his plans for the upcoming G8 and G20 summits], he needs to recognize that healthy mothers come from healthy communities," Maude Barlow and Meera Karunananthan of the Council of Canadians write in a Chronicle Herald opinion piece that examines the connections between the health of women and children and access to drinking water and sanitation.
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. for approximately US$72.6 million.
Angiotech Pharmaceuticals, Inc., today announced the commercial launch of the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System, which it obtained in a supply agreement with privately held Network Medical Products, Ltd. Angiotech will launch the product during the American Academy of Ophthalmology meeting, to be held in San Francisco, CA on October 24-27, 2009.
› Verified 7 days ago